1. Home
  2. SNTI vs FENG Comparison

SNTI vs FENG Comparison

Compare SNTI & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.86

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

HOLD

Current Price

$1.76

Market Cap

20.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNTI
FENG
Founded
2016
1998
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
20.9M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
SNTI
FENG
Price
$0.86
$1.76
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
100.1K
8.8K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
77.31
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7,627.27
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$1.28
52 Week High
$5.10
$3.65

Technical Indicators

Market Signals
Indicator
SNTI
FENG
Relative Strength Index (RSI) 44.15 45.33
Support Level $0.80 $1.72
Resistance Level $1.02 $1.87
Average True Range (ATR) 0.06 0.05
MACD -0.01 -0.01
Stochastic Oscillator 38.33 5.00

Price Performance

Historical Comparison
SNTI
FENG

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

Share on Social Networks: